Therefore, targeting the suppression of SRGAP2 expression in CRC cells, by inhibiting the function and activity of mitochondrial CI, could weaken mitochondrial respiration and increase the sensitivity of CRC cells to chemotherapy. Here, SRGAP2 is linked to colorectal carcinoma.